乳腺瘤中的预测和预后生物标志物
Melissa Krystel-Whittemore1, Puay Hoon Tan2, Hannah Y Wen3
1Department of Pathology, NYU Langone Health, New York, NY, USA.
Pathology
|January 11, 2024
概括
本综述详细介绍了乳腺癌的确立瘤生物标志物,为预测癌症行为和治疗反应提供了对其临床使用的最新见解. 了解这些生物标志物有助于个性化医疗和改善患者预后.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 基因组学就是基因组学.
背景情况:
- 精准医学依赖于识别瘤生物标志物来预测癌症行为和治疗反应.
- 乳腺癌的分类已经通过瘤生物学定义的内在亚型进步.
- 瘤生物标志物对于了解预后和定制治疗策略至关重要.
研究的目的:
- 审查已确定的乳腺癌生物标志物.
- 提供关于它们的理解和临床应用的最新信息.
- 突出其作为预测和预后标记物的作用.
主要方法:
- 对已确定的乳腺癌生物标志物的文献综述.
- 综合当前关于生物标志物理解的数据.
- 在预测和预后中对临床实用性的分析.
主要成果:
- 确定的乳腺癌生物标志物是分型和个性化治疗的关键.
- 介绍了关于生物标志物在预测治疗反应中的作用的最新信息.
- 强调了这些生物标志物的预后和预测价值.
结论:
- 瘤生物标志物对于乳腺癌的精准医学至关重要.
- 持续的研究和生物标志物的应用改善了患者的治疗结果.
- 本综述是乳腺癌生物标志物知识的全面资源.
相关概念视频
01:21Cancer Survival Analysis
353
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
353
02:07Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K